Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation

5Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A T-cell receptor (TCR) with optimal avidity to a tumor antigen can be used to redirect T cells to eradicate cancer cells via adoptive cell transfer. Cancer testis antigens (CTAs) are attractive targets because they are expressed in the testis, which is immune-privileged, and in the tumor. However, CTAs are self-antigens and natural TCRs to CTAs have low affinity/avidity due to central tolerance. We previously described a method of directed evolution of TCR avidity using somatic hypermutation. In this study, we made several improvements to this method and enhanced the avidity of the hT27 TCR, which is specific for the cancer testis antigen HLA-A2-MAGE-A1278-286. We identified eight point mutations with varying degrees of improved avidity. Human T cells transduced with TCRs containing these mutations displayed enhanced tetramer binding, IFN-γ and IL2 production, and cytotoxicity. Most of the mutations have retained specificity, except for one mutant with extremely high avidity. We demonstrate that somatic hypermutation is capable of optimizing avidity of clinically relevant TCRs for immunotherapy.

References Powered by Scopus

PacBio Sequencing and Its Applications

1562Citations
N/AReaders
Get full text

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1393Citations
N/AReaders
Get full text

Adoptive cell transfer: A clinical path to effective cancer immunotherapy

1373Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The landscape of T cell antigens for cancer immunotherapy

45Citations
N/AReaders
Get full text

Characterizing the interaction conformation between T-cell receptors and epitopes with deep learning

21Citations
N/AReaders
Get full text

Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1): A Promising Cancer Testis Antigen

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Bassan, D., Gozlan, Y. M., Sharbi-Yunger, A., Tzehoval, E., Greenstein, E., Bitan, L., … Eisenbach, L. (2021). Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutation. European Journal of Immunology, 51(6), 1505–1518. https://doi.org/10.1002/eji.202049007

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 2

33%

Professor / Associate Prof. 1

17%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

29%

Biochemistry, Genetics and Molecular Bi... 2

29%

Immunology and Microbiology 2

29%

Medicine and Dentistry 1

14%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 150

Save time finding and organizing research with Mendeley

Sign up for free